Mechanistically, BSP-1 regulates the expression of pyroptosis-related proteins and mRNAs in the NLRP3/caspase-1/GSDMD pathway, thereby protecting against MASLD. Here, GSDMD is linked to metabolic dysfunction-associated steatotic liver disease.